Abstract
A homology model for the pig isozyme of the pyridoxal phosphate-dependent enzyme gamma-aminobutyrate (GABA) aminotransferase has been built based mainly on the structure of dialkylglycine decarboxylase and on a multiple sequence alignment of 28 evolutionarily related enzymes. The proposed active site structure is presented and analyzed. Hypothetical structures for external aldimine intermediates explain several characteristics of the enzyme. In the GABA external aldimine model, the pro-S proton at C4 of GABA, which abstracted in the 1,3-azaallylic rearrangement interconverting the aldimine and ketimine intermediates, is oriented perpendicular to the plane of the pyridoxal phosphate ring. Lys 329 is in close proximity and is probably the general base catalyst for the proton transfer reaction. The carboxylate group of GABA interacts with Arg 192 and Lys 203, which determine the specificity of the enzyme for monocarboxylic omega-amino acids such as GABA. In the proposed structure for the L-glutamate external aldimine, the alpha-carboxylate interacts with Arg 445. Glu 265 is proposed to interact with this same arginine in the GABA external aldimine, enabling the enzyme to act on omega-amino acids in one half-reaction and on alpha-amino acids in the other. The reactivities of inhibitors are well explained by the proposed active site structure. The R and S isomers of beta-substituted phenyl and p-chlorophenyl GABA would bind in very different modes due to differential steric interactions, with the reactive S isomer leaving the orientation of the GABA moiety relatively unperturbed compared to that of the natural substrate. In our model, only the reactive S isomer of the mechanism-based inhibitor vinyl-GABA, an effective anti-epileptic drug known clinically as Vigabatrin, would orient the scissile C4-H bond perpendicular to the coenzyme ring plane and present the proton to Lys 329, the proposed general base catalyst of the reaction. The R isomer would direct the vinyl group toward Lys 329 and the C4-H bond toward Arg 445. The active site model presented provides a basis for site-directed mutagenesis and drug design experiments.
Full Text
The Full Text of this article is available as a PDF (2.1 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bajorath J., Stenkamp R., Aruffo A. Knowledge-based model building of proteins: concepts and examples. Protein Sci. 1993 Nov;2(11):1798–1810. doi: 10.1002/pro.5560021103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowie J. U., Lüthy R., Eisenberg D. A method to identify protein sequences that fold into a known three-dimensional structure. Science. 1991 Jul 12;253(5016):164–170. doi: 10.1126/science.1853201. [DOI] [PubMed] [Google Scholar]
- CORDES E. H., JENCKS W. P. Semicarbazone formation from pyridoxal, pyridoxal phosphate, and their Schiff bases. Biochemistry. 1962 Sep;1:773–778. doi: 10.1021/bi00911a007. [DOI] [PubMed] [Google Scholar]
- Choi S. Y., Churchich J. E. 4-Aminobutyrate aminotransferase reaction of sulfhydryl residues connected with catalytic activity. J Biol Chem. 1985 Jan 25;260(2):993–997. [PubMed] [Google Scholar]
- Choi S. Y., Churchich J. E. 4-Aminobutyrate aminotransferase. Conformational changes induced by reduction of pyridoxal 5-phosphate. Biochim Biophys Acta. 1985 Aug 8;830(2):120–126. doi: 10.1016/0167-4838(85)90018-4. [DOI] [PubMed] [Google Scholar]
- Cooper A. J. Glutamate-gamma-aminobutyrate transaminase. Methods Enzymol. 1985;113:80–82. doi: 10.1016/s0076-6879(85)13019-3. [DOI] [PubMed] [Google Scholar]
- De Biase D., Barra D., Bossa F., Pucci P., John R. A. Chemistry of the inactivation of 4-aminobutyrate aminotransferase by the antiepileptic drug vigabatrin. J Biol Chem. 1991 Oct 25;266(30):20056–20061. [PubMed] [Google Scholar]
- De Biase D., Barra D., Simmaco M., John R. A., Bossa F. Primary structure and tissue distribution of human 4-aminobutyrate aminotransferase. Eur J Biochem. 1995 Jan 15;227(1-2):476–480. doi: 10.1111/j.1432-1033.1995.tb20412.x. [DOI] [PubMed] [Google Scholar]
- Dunathan H. C. Conformation and reaction specificity in pyridoxal phosphate enzymes. Proc Natl Acad Sci U S A. 1966 Apr;55(4):712–716. doi: 10.1073/pnas.55.4.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldberg J. M., Swanson R. V., Goodman H. S., Kirsch J. F. The tyrosine-225 to phenylalanine mutation of Escherichia coli aspartate aminotransferase results in an alkaline transition in the spectrophotometric and kinetic pKa values and reduced values of both kcat and Km. Biochemistry. 1991 Jan 8;30(1):305–312. doi: 10.1021/bi00215a041. [DOI] [PubMed] [Google Scholar]
- Kim D. S., Churchich J. E. 4-Aminobutyrate aminotransferase, reaction of P'P2-bis(5'-pyridoxal) diphosphate with lysyl residues connected with catalytic activity. J Biol Chem. 1982 Sep 25;257(18):10991–10995. [PubMed] [Google Scholar]
- Kim D. S., Churchich J. E. The reversible oxidation of vicinal SH groups in 4-aminobutyrate aminotransferase. Probes of conformational changes. J Biol Chem. 1987 Oct 15;262(29):14250–14254. [PubMed] [Google Scholar]
- Kim Y. T., Churchich J. E. 4-Aminobutyrate aminotransferase: identification of lysine residues connected with catalytic activity. Biochim Biophys Acta. 1991 Apr 8;1077(2):187–191. doi: 10.1016/0167-4838(91)90057-7. [DOI] [PubMed] [Google Scholar]
- Kuriyama K., Roberts E., Rubinstein M. K. Elevation of gamma-aminobutyric acid in brain with amino-oxyacetic acid and susceptibility to convulsive seizures in mice: a quantitative re-evaluation. Biochem Pharmacol. 1966 Mar;15(3):221–236. doi: 10.1016/0006-2952(66)90293-0. [DOI] [PubMed] [Google Scholar]
- Mehta P. K., Christen P. Homology of 1-aminocyclopropane-1-carboxylate synthase, 8-amino-7-oxononanoate synthase, 2-amino-6-caprolactam racemase, 2,2-dialkylglycine decarboxylase, glutamate-1-semialdehyde 2,1-aminomutase and isopenicillin-N-epimerase with aminotransferases. Biochem Biophys Res Commun. 1994 Jan 14;198(1):138–143. doi: 10.1006/bbrc.1994.1020. [DOI] [PubMed] [Google Scholar]
- Morris A. L., MacArthur M. W., Hutchinson E. G., Thornton J. M. Stereochemical quality of protein structure coordinates. Proteins. 1992 Apr;12(4):345–364. doi: 10.1002/prot.340120407. [DOI] [PubMed] [Google Scholar]
- Silverman R. B., Invergo B. J., Levy M. A., Andrew C. R. Substrate stereospecificity and active site topography of gamma-aminobutyric acid aminotransferase for beta-aryl-gamma-aminobutyric acid analogues. J Biol Chem. 1987 Mar 5;262(7):3192–3195. [PubMed] [Google Scholar]
- Toney M. D., Hohenester E., Cowan S. W., Jansonius J. N. Dialkylglycine decarboxylase structure: bifunctional active site and alkali metal sites. Science. 1993 Aug 6;261(5122):756–759. doi: 10.1126/science.8342040. [DOI] [PubMed] [Google Scholar]
- Toney M. D., Kirsch J. F. Lysine 258 in aspartate aminotransferase: enforcer of the Circe effect for amino acid substrates and general-base catalyst for the 1,3-prototropic shift. Biochemistry. 1993 Feb 16;32(6):1471–1479. doi: 10.1021/bi00057a010. [DOI] [PubMed] [Google Scholar]
- Yano T., Kuramitsu S., Tanase S., Morino Y., Hiromi K., Kagamiyama H. The role of His143 in the catalytic mechanism of Escherichia coli aspartate aminotransferase. J Biol Chem. 1991 Apr 5;266(10):6079–6085. [PubMed] [Google Scholar]
- Yano T., Kuramitsu S., Tanase S., Morino Y., Kagamiyama H. Role of Asp222 in the catalytic mechanism of Escherichia coli aspartate aminotransferase: the amino acid residue which enhances the function of the enzyme-bound coenzyme pyridoxal 5'-phosphate. Biochemistry. 1992 Jun 30;31(25):5878–5887. doi: 10.1021/bi00140a025. [DOI] [PubMed] [Google Scholar]
- Yu P. H., Durden D. A., Davis B. A., Boulton A. A. Deuterium isotope effect in gamma-aminobutyric acid transamination: determination of rate-limiting step. J Neurochem. 1987 Feb;48(2):440–446. doi: 10.1111/j.1471-4159.1987.tb04112.x. [DOI] [PubMed] [Google Scholar]